Novo Holdings has agreed to acquire Pritzker Private Capital's KabaFusion, a home infusion company specializing in intravenous immunoglobulin (IVIG),sources tell Axios.
Why it matters: The home infusion market is highly fragmented, presenting an opportunity to create another large, diversified platform consolidator more akin to the big two: OptumRx and Option Care Health. Freshly-backed KabaFusion could be that starting point.
